- Home
- Publications
- Publication Search
- Publication Details
Title
Will new antimicrobials overcome resistance among Gram-negatives?
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 9, Issue 10, Pages 909-922
Publisher
Informa UK Limited
Online
2011-11-07
DOI
10.1586/eri.11.107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In VitroandIn VivoProperties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases
- (2011) Malcolm G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009
- (2011) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases
- (2011) P. R. S. Lagacé-Wiens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14– and CTX-M-15–producing Escherichia coli and Klebsiella pneumoniae
- (2011) Emilia Titelman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of a novel combination against multidrug-resistant nonfermenters: ceftazidime plus NXL104
- (2011) Daniel Curcio Expert Review of Anti-Infective Therapy
- In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii
- (2011) T. A. Russo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Does broad-spectrum -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
- (2011) P. Nordmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Doripenem: A new carbapenem antibiotic
- (2010) E. B. Chahine et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- In Vitro Potentiation of Carbapenems with ME1071, a Novel Metallo- -Lactamase Inhibitor, against Metallo- -Lactamase- Producing Pseudomonas aeruginosa Clinical Isolates
- (2010) Y. Ishii et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates
- (2010) M. M. Butler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a New Cephalosporin, CXA-101 (FR264205), against -Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of CXA-101, a New Antipseudomonal Cephalosporin, in Healthy Adult Male and Female Subjects Receiving Single- and Multiple-Dose Intravenous Infusions
- (2010) Y. Ge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design and synthesis of potent Gram-negative specific LpxC inhibitors
- (2010) U. Faruk Mansoor et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Multicenter, Randomized Controlled Clinical Study on Biapenem and Imipenem/Cilastatin Injection in the Treatment of Respiratory and Urinary Tract Infections
- (2010) Bei Jia et al. CHEMOTHERAPY
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States
- (2010) Pornpan Koomanachai et al. CLINICAL THERAPEUTICS
- Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
- (2010) Lisa L. Maragakis CRITICAL CARE MEDICINE
- Resistance to polymyxins: Mechanisms, frequency and treatment options
- (2010) Matthew E. Falagas et al. DRUG RESISTANCE UPDATES
- Current Challenges in Antimicrobial Chemotherapy
- (2010) Carine Bebrone et al. DRUGS
- Activity of doripenem against extended-spectrum β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates
- (2010) C. Betriu et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Ceftaroline for complicated skin and skin-structure infections
- (2010) Esteban C Nannini et al. EXPERT OPINION ON PHARMACOTHERAPY
- New aminoglycoside antibiotics
- (2010) Paola Dozzo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes
- (2010) George H. Talbot INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Current Epidemiology of Multidrug-Resistant Gram-Negative Bacilli in the United States
- (2010) Alexander J. Kallen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Relation between the Antimicrobial Susceptibility of Clinical Isolates of Pseudomonas aeruginosa from Respiratory Specimens and Antimicrobial Use Density (AUD) from 2005 through 2008
- (2010) Yasutsugu Fukushima et al. INTERNAL MEDICINE
- Emerging carbapenemases: a global perspective
- (2010) Timothy R. Walsh INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
- (2010) Yvonne Pfeifer et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of chequerboard combinations of ceftaroline and NXL104 versus -lactamase-producing Enterobacteriaceae
- (2010) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
- (2010) B. A. Rogers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues
- (2010) K. S. Thomson JOURNAL OF CLINICAL MICROBIOLOGY
- Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007
- (2010) Kazunori Gomi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Promiscuous DNA: horizontal transfer of transposable elements and why it matters for eukaryotic evolution
- (2010) Sarah Schaack et al. TRENDS IN ECOLOGY & EVOLUTION
- Antimicrobial Peptides: Primeval Molecules or Future Drugs?
- (2010) Brian M. Peters et al. PLoS Pathogens
- Efficacy of Piperacillin Combined with the Penem -Lactamase Inhibitor BLI-489 in Murine Models of Systemic Infection
- (2009) P. J. Petersen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hydrolysis and Inhibition Profiles of -Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem
- (2009) A. M. Queenan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including -Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
- (2009) C. Vidaillac et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESCAPE Revisited
- (2009) Lance R. Peterson CLINICAL INFECTIOUS DISEASES
- The Spread ofKlebsiella pneumoniaeCarbapenemases: A Tale of Strains, Plasmids, and Transposons
- (2009) L. Silvia Munoz‐Price et al. CLINICAL INFECTIOUS DISEASES
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*
- (2009) Jean Chastre et al. CRITICAL CARE MEDICINE
- Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update
- (2009) M. Shahid et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Current Status of Newer Carbapenems
- (2009) Matteo Bassetti et al. CURRENT MEDICINAL CHEMISTRY
- Prospects for the next anti-Pseudomonas drug
- (2009) Malcolm GP Page et al. CURRENT OPINION IN PHARMACOLOGY
- Ceftobiprole: a new broad spectrum cephalosporin
- (2009) Ali A El Solh EXPERT OPINION ON PHARMACOTHERAPY
- Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-resistant Staphylococcus aureus, Produced by Streptomyces sp. K04-0144
- (2009) Atsushi Fukumoto et al. JOURNAL OF ANTIBIOTICS
- ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia
- (2009) I. Morrissey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance development profiling of piperacillin in combination with the novel -lactamase inhibitor BLI-489
- (2009) A. Ruzin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
- (2009) Garyphallia Poulakou et al. JOURNAL OF INFECTION
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
- (2009) Patrice Nordmann et al. LANCET INFECTIOUS DISEASES
- Potent In Vitro Activity of Tomopenem (CS-023) against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa
- (2008) T. Koga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum -Lactamase Inhibitor
- (2008) S. Paukner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
- (2008) G. J. Noel et al. CLINICAL INFECTIOUS DISEASES
- Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial
- (2008) A.C. Rodloff et al. CLINICAL MICROBIOLOGY AND INFECTION
- Novel β-lactam antibiotics and inhibitor combinations
- (2008) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
- (2008) M. Baer et al. INFECTION AND IMMUNITY
- Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?
- (2008) Helen C. Maltezou INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acinetobacter Infection
- (2008) L. Silvia Munoz-Price et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started